LeBlanc Dorian Paul 4

What Happened
Dorian Paul LeBlanc, CFO of LeMaitre Vascular, was credited on 2026-06-04 with two sets of dividend-equivalent rights totaling 5.628 units (2.476 and 3.152 units). Both were reported as awards/other acquisitions (transaction code A) at $0.00 — these are derivative rights tied to previously granted restricted stock unit (RSU) awards, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-04; Form filed 2026-06-05 (filed the next day).
• Items acquired: 2.476 and 3.152 dividend-equivalent rights; total = 5.628 units. Price per unit: $0.00 (derivative grant).
• Shares owned after the transaction: not specified in the provided filing.
• Footnotes:
  • F1 — The 2.476 units are dividend equivalent rights that accrued on an RSU grant dated 03/10/2025 and vest proportionately with that RSU.
  • F2 — The 3.152 units are dividend equivalent rights that accrued on an RSU grant dated 12/10/2025 and vest proportionately with that RSU.
• These are derivative dividend-equivalent rights (economic equivalent of one share each when vested), not immediate stock delivery or a cash purchase.

Context
Dividend-equivalent rights typically accrue as part of equity compensation and convert or pay out in line with the underlying RSU vesting schedule. Such awards are routine compensation and do not by themselves signal a buy/sell decision by the insider.